ATE500316T1 - Antibakterielle impfstoffzusammensetzungen - Google Patents

Antibakterielle impfstoffzusammensetzungen

Info

Publication number
ATE500316T1
ATE500316T1 AT02705915T AT02705915T ATE500316T1 AT E500316 T1 ATE500316 T1 AT E500316T1 AT 02705915 T AT02705915 T AT 02705915T AT 02705915 T AT02705915 T AT 02705915T AT E500316 T1 ATE500316 T1 AT E500316T1
Authority
AT
Austria
Prior art keywords
vaccine compositions
antibacterial vaccine
antibacterial
compositions
vaccine
Prior art date
Application number
AT02705915T
Other languages
German (de)
English (en)
Inventor
David Lowery
Troy Fuller
Michael Kennedy
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE500316T1 publication Critical patent/ATE500316T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02705915T 2001-03-15 2002-01-17 Antibakterielle impfstoffzusammensetzungen ATE500316T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/809,665 US6790950B2 (en) 1999-04-09 2001-03-15 Anti-bacterial vaccine compositions
PCT/US2002/001971 WO2002075507A2 (en) 2001-03-15 2002-01-17 Anti-bacterial vaccine compositions

Publications (1)

Publication Number Publication Date
ATE500316T1 true ATE500316T1 (de) 2011-03-15

Family

ID=25201919

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02705915T ATE500316T1 (de) 2001-03-15 2002-01-17 Antibakterielle impfstoffzusammensetzungen

Country Status (18)

Country Link
US (2) US6790950B2 (enExample)
EP (1) EP1368456B1 (enExample)
JP (2) JP2005502315A (enExample)
AR (2) AR035745A1 (enExample)
AT (1) ATE500316T1 (enExample)
AU (1) AU2002240033B2 (enExample)
CA (2) CA2438315C (enExample)
CY (1) CY1112014T1 (enExample)
DE (1) DE60239318D1 (enExample)
DK (1) DK1368456T3 (enExample)
ES (1) ES2362041T3 (enExample)
MX (1) MXPA03008296A (enExample)
NZ (1) NZ528208A (enExample)
PE (1) PE20021008A1 (enExample)
PT (1) PT1368456E (enExample)
SI (1) SI1368456T1 (enExample)
TW (4) TWI335935B (enExample)
WO (1) WO2002075507A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455323B1 (en) * 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) * 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
WO2002034771A2 (en) 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
US7794734B2 (en) * 2002-10-30 2010-09-14 The Board Of Regents For Oklahoma State University Mannheimia haemolytica chimeric outer membrane protein PlpE and leukotoxin epitopes as a vaccine or vaccine component against shipping fever
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
EP1648500B1 (en) 2003-07-31 2014-07-09 Novartis Vaccines and Diagnostics, Inc. Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US9107864B2 (en) * 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
EP2073829B1 (en) * 2006-10-05 2012-06-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
US8937154B2 (en) 2006-10-05 2015-01-20 New York Blood Center, Inc. Stabilized therapeutic small helical antiviral peptides
AU2008299376B2 (en) 2007-09-12 2013-02-28 Glaxosmithkline Biologicals S.A. GAS57 mutant antigens and GAS57 antibodies
JP2011522796A (ja) 2008-05-06 2011-08-04 ニューヨーク ブラッド センター， インコーポレイテッド 抗ウイルス細胞透過性ペプチド
CA2729818A1 (en) * 2008-07-03 2010-01-07 Biotechnology Research And Development Corporation Vaccines comprising pasteurella multocida recombinant filamentous hemagglutinin peptides
CA2774636C (en) 2009-09-25 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing antibodies to hiv-1 and their use
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9757445B2 (en) 2013-11-01 2017-09-12 Merial Inc. Attenuated Pasteurella multocida vaccines and methods of making and use thereof
CN116593695B (zh) * 2022-12-29 2025-08-05 重庆澳龙生物制品有限公司 一种牛多杀性巴氏杆菌荚膜a型elisa抗体检测试剂盒及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735801A (en) 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US5077044A (en) 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
DK166762B1 (da) 1986-01-14 1993-07-12 Nederlanden Staat Fremgangsmaade til fremstilling af immunogenkomplekser og farmaceutisk sammensaetning indeholdende saadanne komplekser
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
IL86583A0 (en) 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
PL170938B1 (pl) 1991-03-05 1997-02-28 Wellcome Found Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL
US5840312A (en) 1991-05-02 1998-11-24 Institut Pasteur Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
WO1994011024A1 (en) 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
US5585277A (en) 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
WO1995020652A1 (de) 1994-01-28 1995-08-03 Medigene Gmbh Verfahren zur bestimmung der aktivität eines regulatorischen faktors sowie verwendung dieses verfahrens
KR100445103B1 (ko) 1994-12-09 2004-12-04 임페리얼 컬리지 이노베이션스 리미티드 유전자의동정
GB9518220D0 (en) 1995-09-06 1995-11-08 Medical Res Council Checkpoint gene
BR9713195A (pt) * 1996-09-06 1999-12-21 Peter Ruhdal Jensen Método de aperfeiçoamento da produção de biomassa ou de um produto desejado de uma célula.
US6673538B1 (en) * 1997-07-25 2004-01-06 The Trustees Of Boston University Methods and compositions for designing vaccines
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
JP4892134B2 (ja) 1999-04-09 2012-03-07 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗菌ワクチン組成物
US6376211B1 (en) * 1999-07-12 2002-04-23 Xoma Technology Ltd. Agents and methods for inhibiting F1/F0 ATPase
DE60124526D1 (de) * 2000-04-27 2006-12-28 Max Planck Gesellschaft Methode zur identifizierung von helicobacter antigenen

Also Published As

Publication number Publication date
WO2002075507A2 (en) 2002-09-26
TW201040261A (en) 2010-11-16
TWI334884B (en) 2010-12-21
NZ528208A (en) 2008-04-30
DE60239318D1 (de) 2011-04-14
CA2438315C (en) 2014-09-02
AR035745A1 (es) 2004-07-07
EP1368456B1 (en) 2011-03-02
MXPA03008296A (es) 2007-05-28
TWI328035B (en) 2010-08-01
JP2005502315A (ja) 2005-01-27
US20050003512A1 (en) 2005-01-06
AU2002240033B2 (en) 2007-11-08
PT1368456E (pt) 2011-06-01
SI1368456T1 (sl) 2011-06-30
CY1112014T1 (el) 2015-11-04
JP2011097938A (ja) 2011-05-19
US20040110268A1 (en) 2004-06-10
US6790950B2 (en) 2004-09-14
CA2438315A1 (en) 2002-09-26
ES2362041T3 (es) 2011-06-27
PE20021008A1 (es) 2002-11-13
DK1368456T3 (da) 2011-05-23
WO2002075507B1 (en) 2003-12-11
AR071888A2 (es) 2010-07-21
TW200916577A (en) 2009-04-16
CA2852293A1 (en) 2002-09-26
TWI335935B (en) 2011-01-11
TW201040262A (en) 2010-11-16
WO2002075507A3 (en) 2003-09-12
TWI335934B (en) 2011-01-11
US7476391B2 (en) 2009-01-13
EP1368456A2 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
DK1390066T3 (da) Vaccinesammensætning
FI20010780A0 (fi) Parannetut koostumukset
DE60230760D1 (de) Grippe-impfstoffzusammensetzung
NO20026175L (no) Vaksinesammensetning
DE60232172D1 (de) Nanocomposit-widerstands zusammensetzungen
IS6915A (is) Lyfjablanda
FI20011478A0 (fi) Farmaseuttinen koostumus
DE60100567D1 (de) Antimikrobielle zusammensetzungen
DE60109207T8 (de) Orale zusammensetzung
IS7297A (is) Streptococcis Pneumoniae bóluefni
DK1427444T3 (da) West-nil-vaccine
BR0210619A (pt) composição
ATE500316T1 (de) Antibakterielle impfstoffzusammensetzungen
IS7081A (is) Lyfjablanda
NO20033882D0 (no) Vaksine
EE200300589A (et) Ravimkoostised
DE60234592D1 (de) Wässrige zusammensetzung
DE60135877D1 (de) Antibakterielle zusammensetzung
PT1238587E (pt) Composicoes de biopesticidas
EP1420818A4 (en) ANTIGENIC COMPOSITIONS
ITTO20020744A0 (it) Composizione
ITMI20010884A0 (it) Composizioni detergenti
ATE549920T1 (de) Insektizide zusammensetzung
NO20030946L (no) Medisinske sammensetninger
ITTO20020745A0 (it) Composizione

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368456

Country of ref document: EP